Search

Your search keyword '"Hausleiter J"' showing total 836 results
Start Over Author "Hausleiter J"

Refine your results

more »

more »

more »

more »

more »
836 results on '"Hausleiter J"'

3. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

Author

Dreyfus, J, Galloo, X, Taramasso, M, Heitzinger, G, Benfari, G, Kresoja, K, Juarez-Casso, F, Omran, H, Bohbot, Y, Iliadis, C, Russo, G, Topilsky, Y, Weber, M, Nombela-Franco, L, Sala, A, Eixerés-Esteve, A, Iung, B, Obadia, J, Estevez Loureiro, R, Riant, E, Donal, E, Hausleiter, J, Badano, L, Le Tourneau, T, Coisne, A, Modine, T, Latib, A, Praz, F, Windecker, S, Zamorano, J, von Bardeleben, R, Tang, G, Hahn, R, Webb, J, Muraru, D, Nejjari, M, Chan, V, De Bonis, M, Carnero-Alcazar, M, Nickenig, G, Pfister, R, Tribouilloy, C, Rudolph, V, Crestanello, J, Lurz, P, Bartko, P, Maisano, F, Bax, J, Enriquez-Sarano, M, Messika-Zeitoun, D, Dreyfus, Julien, Galloo, Xavier, Taramasso, Maurizio, Heitzinger, Gregor, Benfari, Giovanni, Kresoja, Karl-Patrick, Juarez-Casso, Fernando, Omran, Hazem, Bohbot, Yohann, Iliadis, Christos, Russo, Giulio, Topilsky, Yan, Weber, Marcel, Nombela-Franco, Luis, Sala, Alessandra, Eixerés-Esteve, Andrea, Iung, Bernard, Obadia, Jean-François, Estevez Loureiro, Rodrigo, Riant, Elisabeth, Donal, Erwan, Hausleiter, Jörg, Badano, Luigi, Le Tourneau, Thierry, Coisne, Augustin, Modine, Thomas, Latib, Azeem, Praz, Fabien, Windecker, Stephan, Zamorano, Jose Luis, von Bardeleben, Ralph Stephan, Tang, Gilbert H L, Hahn, Rebecca, Webb, John, Muraru, Denisa, Nejjari, Mohammed, Chan, Vincent, De Bonis, Michele, Carnero-Alcazar, Manuel, Nickenig, Georg, Pfister, Roman, Tribouilloy, Christophe, Rudolph, Volker, Crestanello, Juan, Lurz, Philipp, Bartko, Philipp, Maisano, Francesco, Bax, Jeroen, Enriquez-Sarano, Maurice, Messika-Zeitoun, David, Dreyfus, J, Galloo, X, Taramasso, M, Heitzinger, G, Benfari, G, Kresoja, K, Juarez-Casso, F, Omran, H, Bohbot, Y, Iliadis, C, Russo, G, Topilsky, Y, Weber, M, Nombela-Franco, L, Sala, A, Eixerés-Esteve, A, Iung, B, Obadia, J, Estevez Loureiro, R, Riant, E, Donal, E, Hausleiter, J, Badano, L, Le Tourneau, T, Coisne, A, Modine, T, Latib, A, Praz, F, Windecker, S, Zamorano, J, von Bardeleben, R, Tang, G, Hahn, R, Webb, J, Muraru, D, Nejjari, M, Chan, V, De Bonis, M, Carnero-Alcazar, M, Nickenig, G, Pfister, R, Tribouilloy, C, Rudolph, V, Crestanello, J, Lurz, P, Bartko, P, Maisano, F, Bax, J, Enriquez-Sarano, M, Messika-Zeitoun, D, Dreyfus, Julien, Galloo, Xavier, Taramasso, Maurizio, Heitzinger, Gregor, Benfari, Giovanni, Kresoja, Karl-Patrick, Juarez-Casso, Fernando, Omran, Hazem, Bohbot, Yohann, Iliadis, Christos, Russo, Giulio, Topilsky, Yan, Weber, Marcel, Nombela-Franco, Luis, Sala, Alessandra, Eixerés-Esteve, Andrea, Iung, Bernard, Obadia, Jean-François, Estevez Loureiro, Rodrigo, Riant, Elisabeth, Donal, Erwan, Hausleiter, Jörg, Badano, Luigi, Le Tourneau, Thierry, Coisne, Augustin, Modine, Thomas, Latib, Azeem, Praz, Fabien, Windecker, Stephan, Zamorano, Jose Luis, von Bardeleben, Ralph Stephan, Tang, Gilbert H L, Hahn, Rebecca, Webb, John, Muraru, Denisa, Nejjari, Mohammed, Chan, Vincent, De Bonis, Michele, Carnero-Alcazar, Manuel, Nickenig, Georg, Pfister, Roman, Tribouilloy, Christophe, Rudolph, Volker, Crestanello, Juan, Lurz, Philipp, Bartko, Philipp, Maisano, Francesco, Bax, Jeroen, Enriquez-Sarano, Maurice, and Messika-Zeitoun, David

Abstract

BACKGROUND AND AIMS: Benefit of tricuspid regurgitation (TR) correction and timing of intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter intervention to conservative management according to a TR clinical stage as assessed using the TRI-SCORE. METHODS: A total of 2,413 patients with severe isolated functional TR were enrolled in TRIGISTRY (1217 conservatively managed, 551 isolated tricuspid valve surgery, and 645 transcatheter valve repair). The primary endpoint was survival at 2 years. RESULTS: The TRI-SCORE was low (≤3) in 32%, intermediate (4-5) in 33%, and high (≥6) in 35%. A successful correction was achieved in 97% and 65% of patients in the surgical and transcatheter groups, respectively. Survival rates decreased with the TRI-SCORE in the three treatment groups (all P < .0001). In the low TRI-SCORE category, survival rates were higher in the surgical and transcatheter groups than in the conservative management group (93%, 87%, and 79%, respectively, P = .0002). In the intermediate category, no significant difference between groups was observed overall (80%, 71%, and 71%, respectively, P = .13) but benefit of the intervention became significant when the analysis was restricted to patients with successful correction (80%, 81%, and 71%, respectively, P = .009). In the high TRI-SCORE category, survival was not different to conservative management in the surgical and successful repair group (61% and 68% vs 58%, P = .26 and P = .18 respectively). CONCLUSIONS: Survival progressively decreased with the TRI-SCORE irrespective of treatment modality. Compared to conservative management, an early and successful surgical or transcatheter intervention improved 2-year survival in patients at low and, to a lower extent, intermediate TRI-SCORE, while no benefit was observed in the high TRI-SCORE category.

Published
2024

5. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

Author

Hahn, R, Lawlor, M, Davidson, C, Badhwar, V, Sannino, A, Spitzer, E, Lurz, P, Lindman, B, Topilsky, Y, Baron, S, Chadderdon, S, Khalique, O, Tang, G, Taramasso, M, Grayburn, P, Badano, L, Leipsic, J, Lindenfeld, J, Windecker, S, Vemulapalli, S, Redfors, B, Alu, M, Cohen, D, Rodes-Cabau, J, Ailawadi, G, Mack, M, Ben-Yehuda, O, Leon, M, Hausleiter, J, Arnold, S, Bapat, V, Berry, N, Blanke, P, Burkhoff, D, Coylewright, M, Duggal, N, Galper, B, George, I, Guerrero, M, Hamid, N, Jagadeesan, V, Kodali, S, Krucoff, M, Lang, R, Madhavan, M, Mclaughin, V, Mehran, R, Philippon, F, Sethi, S, Simonato, M, Smith, R, Sodhi, N, Spertus, J, Stocker, T, Stone, G, Hahn R. T., Lawlor M. K., Davidson C. J., Badhwar V., Sannino A., Spitzer E., Lurz P., Lindman B. R., Topilsky Y., Baron S. J., Chadderdon S., Khalique O. K., Tang G. H. L., Taramasso M., Grayburn P. A., Badano L., Leipsic J., Lindenfeld J., Windecker S., Vemulapalli S., Redfors B., Alu M. C., Cohen D. J., Rodes-Cabau J., Ailawadi G., Mack M., Ben-Yehuda O., Leon M. B., Hausleiter J., Arnold S., Bapat V., Berry N., Blanke P., Burkhoff D., Coylewright M., Duggal N., Galper B., George I., Guerrero M., Hamid N., Jagadeesan V., Kodali S., Krucoff M., Lang R., Madhavan M., McLaughin V., Mehran R., Philippon F., Sethi S. S., Simonato M., Smith R., Sodhi N., Spertus J., Stocker T. J., Stone G., Hahn, R, Lawlor, M, Davidson, C, Badhwar, V, Sannino, A, Spitzer, E, Lurz, P, Lindman, B, Topilsky, Y, Baron, S, Chadderdon, S, Khalique, O, Tang, G, Taramasso, M, Grayburn, P, Badano, L, Leipsic, J, Lindenfeld, J, Windecker, S, Vemulapalli, S, Redfors, B, Alu, M, Cohen, D, Rodes-Cabau, J, Ailawadi, G, Mack, M, Ben-Yehuda, O, Leon, M, Hausleiter, J, Arnold, S, Bapat, V, Berry, N, Blanke, P, Burkhoff, D, Coylewright, M, Duggal, N, Galper, B, George, I, Guerrero, M, Hamid, N, Jagadeesan, V, Kodali, S, Krucoff, M, Lang, R, Madhavan, M, Mclaughin, V, Mehran, R, Philippon, F, Sethi, S, Simonato, M, Smith, R, Sodhi, N, Spertus, J, Stocker, T, Stone, G, Hahn R. T., Lawlor M. K., Davidson C. J., Badhwar V., Sannino A., Spitzer E., Lurz P., Lindman B. R., Topilsky Y., Baron S. J., Chadderdon S., Khalique O. K., Tang G. H. L., Taramasso M., Grayburn P. A., Badano L., Leipsic J., Lindenfeld J., Windecker S., Vemulapalli S., Redfors B., Alu M. C., Cohen D. J., Rodes-Cabau J., Ailawadi G., Mack M., Ben-Yehuda O., Leon M. B., Hausleiter J., Arnold S., Bapat V., Berry N., Blanke P., Burkhoff D., Coylewright M., Duggal N., Galper B., George I., Guerrero M., Hamid N., Jagadeesan V., Kodali S., Krucoff M., Lang R., Madhavan M., McLaughin V., Mehran R., Philippon F., Sethi S. S., Simonato M., Smith R., Sodhi N., Spertus J., Stocker T. J., and Stone G.

Abstract

Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency and enable meaningful comparisons between clinical trials. A second Tricuspid Valve Academic Research Consortium document will focus on further defining trial endpoints and will discuss trial design options.

Published
2023

6. Current trends in patients with chronic total occlusions undergoing coronary CT angiography

Author

Opolski, MP, Hartaigh, BO, Berman, DS, Budoff, MJ, Achenbach, S, Al-Mallah, M, Andreini, D, Cademartiri, F, Chang, HJ, Chinnaiyan, K, Chow, BJW, Hadamitzky, M, Hausleiter, J, Feuchtner, G, Kim, YJ, Kaufmann, PA, Leipsic, J, Maffei, E, Pontone, G, Raff, G, Shaw, LJ, Villines, TC, and Min, JK

Subjects
Cardiovascular System & Hematology, Cardiorespiratory Medicine and Haematology
Abstract

Objective: Data describing the prevalence, characteristics and management of coronary chronic total occlusions (CTOs) in patients undergoing coronary CT angiography (CCTA) have not been reported. The purpose of this study was to determine the prevalence, characteristics and treatment strategies of CTO identified by CCTA. Methods: We identified 23 745 patients who underwent CCTA for suspected coronary artery disease (CAD) from the prospective international CCTA registry. Baseline clinical data were collected, and allocation to early coronary revascularisation performed within 90 days of CCTA was determined. Multivariable hierarchical mixed-effects logistic regression reporting OR with 95% CI was performed. Results: The prevalence of CTO was 1.4% (342/23 745) in all patients and 6.2% in patients with obstructive CAD (≥50% stenosis). The presence of CTO was independently associated with male sex (OR 3.12, 95% CI 2.39 to 4.08, p

Published
2015

7. A Clinical model to identify patients with high-risk coronary artery disease

Author

Yang, Y, Chen, L, Yam, Y, Achenbach, S, Al-Mallah, M, Berman, DS, Budoff, MJ, Cademartiri, F, Callister, TQ, Chang, HJ, Cheng, VY, Chinnaiyan, K, Cury, R, Delago, A, Dunning, A, Feuchtner, G, Hadamitzky, M, Hausleiter, J, Karlsberg, RP, Kaufmann, PA, Kim, YJ, Leipsic, J, Labounty, T, Lin, F, Maffei, E, Raff, GL, Shaw, LJ, Villines, TC, Min, JK, and Chow, BJW

Subjects
Cardiorespiratory Medicine and Haematology, Clinical Sciences, Cardiovascular System & Hematology
Abstract

Objectives This study sought to develop a clinical model that identifies patients with and without high-risk coronary artery disease (CAD). Background Although current clinical models help to estimate a patient's pre-test probability of obstructive CAD, they do not accurately identify those patients with and without high-risk coronary anatomy. Methods Retrospective analysis of a prospectively collected multinational coronary computed tomographic angiography (CTA) cohort was conducted. High-risk anatomy was defined as left main diameter stenosis ≥50%, 3-vessel disease with diameter stenosis ≥70%, or 2-vessel disease involving the proximal left anterior descending artery. Using a cohort of 27,125, patients with a history of CAD, cardiac transplantation, and congenital heart disease were excluded. The model was derived from 24,251 consecutive patients in the derivation cohort and an additional 7,333 nonoverlapping patients in the validation cohort. Results The risk score consisted of 9 variables: age, sex, diabetes, hypertension, current smoking, hyperlipidemia, family history of CAD, history of peripheral vascular disease, and chest pain symptoms. Patients were divided into 3 risk categories: low (≤7 points), intermediate (8 to 17 points) and high (≥18 points). The model was statistically robust with area under the curve of 0.76 (95% confidence interval [CI]: 0.75 to 0.78) in the derivation cohort and 0.71 (95% CI: 0.69 to 0.74) in the validation cohort. Patients who scored ≤7 points had a low negative likelihood ratio (

Published
2015

9. NYHA class IV in patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair: Results of the worldwide, multicenter PRIME-MR registry

Author

Koell, B, primary, Ludwig, S, additional, Weimann, J, additional, Scotti, A, additional, Weber, M, additional, Iliadis, C, additional, Xhepa, E, additional, Dreyfus, J, additional, Paradis, J M, additional, Praz, F, additional, Modine, T, additional, Hausleiter, J, additional, Donal, E, additional, Coisne, A, additional, and Kalbacher, D, additional

Published
2023
Full Text
View/download PDF

10. Reduction of cardiac allograft vasculopathy by PCI: Quantification and correlation with outcome after heart transplantation

Author

Orban, M, primary, Kuehl, A, additional, Pechmajou, L, additional, Mueller, C, additional, Hausleiter, J, additional, Sfeir, M, additional, Bories, M C, additional, Martin, A C, additional, Ulrich, S M, additional, Dalla Pozza, R, additional, Mehilli, J, additional, Jouven, X, additional, Hagl, C, additional, Karam, N, additional, and Massberg, S, additional

Published
2023
Full Text
View/download PDF

11. Right-ventricular/pulmonary artery coupling predicts long-term mortality in aortic stenosis patients with different flow types

Author

Steffen, J, primary, Lux, M, additional, Kneidinger, N, additional, Stocker, T, additional, Low, K, additional, Doldi, P, additional, Haum, M, additional, Fischer, J, additional, Stolz, L, additional, Theiss, H, additional, Rizas, K, additional, Peterss, S, additional, Hausleiter, J, additional, Massberg, S, additional, and Deseive, S, additional

Published
2023
Full Text
View/download PDF

13. Early outcomes of the PASCAL P10 and the MitraClip XT transcatheter mitral leaflet approximation devices - A propensity score matched multicentre comparison

Author

Von Stein, P, primary, Wienemann, H, additional, Horn, P, additional, Sugiura, A, additional, Spieker, M, additional, Tanaka, T, additional, Lurz, P, additional, Ruf, T, additional, Grothusen, C, additional, Hausleiter, J, additional, Nef, H, additional, Luedike, P, additional, Gercek, M, additional, Pfister, R, additional, and Mauri, V, additional

Published
2023
Full Text
View/download PDF

20. Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry

Author

Russo, G, Badano, L, Adamo, M, Alessandrini, H, Andreas, M, Braun, D, Connelly, K, Denti, P, Estevez-Loureiro, R, Fam, N, Gavazzoni, M, Hahn, R, Harr, C, Hausleiter, J, Himbert, D, Kalbacher, D, Ho, E, Latib, A, Lubos, E, Ludwig, S, Lurz, P, Monivas, V, Nickenig, G, Pedicino, D, Pedrazzini, G, Pozzoli, A, Marafon, D, Pastorino, R, Praz, F, Rodes-Cabau, J, Besler, C, Schofer, J, Scotti, A, Piayda, K, Sievert, H, Tang, G, Thiele, H, Schlotter, F, von Bardeleben, R, Webb, J, Windecker, S, Leon, M, Maisano, F, Metra, M, Taramasso, M, Connelly, KA, Hahn, RT, Marafon, DP, Tang, GHL, von Bardeleben, RS, Russo, G, Badano, L, Adamo, M, Alessandrini, H, Andreas, M, Braun, D, Connelly, K, Denti, P, Estevez-Loureiro, R, Fam, N, Gavazzoni, M, Hahn, R, Harr, C, Hausleiter, J, Himbert, D, Kalbacher, D, Ho, E, Latib, A, Lubos, E, Ludwig, S, Lurz, P, Monivas, V, Nickenig, G, Pedicino, D, Pedrazzini, G, Pozzoli, A, Marafon, D, Pastorino, R, Praz, F, Rodes-Cabau, J, Besler, C, Schofer, J, Scotti, A, Piayda, K, Sievert, H, Tang, G, Thiele, H, Schlotter, F, von Bardeleben, R, Webb, J, Windecker, S, Leon, M, Maisano, F, Metra, M, Taramasso, M, Connelly, KA, Hahn, RT, Marafon, DP, Tang, GHL, and von Bardeleben, RS

Abstract

Aim Functional or secondary tricuspid regurgitation (STR) is the most common phenotype of tricuspid regurgitation (TR) with atrial STR (ASTR) and ventricular STR (VSTR) being recently identified as two distinct entities. Data on tricuspid transcatheter edge-to-edge repair (T-TEER) in patients with STR according to phenotype (i.e. ASTR vs. VSTR) are lacking. The aim of this study was to assess characteristics and outcomes of patients with ASTR versus VSTR undergoing T-TEER. Methods and results Patients with STR undergoing T-TEER were selected from the Transcatheter Tricuspid Valve Therapies (TriValve) registry. ASTR was defined by (i) left ventricular ejection fraction >= 50%, (ii) atrial fibrillation, and (iii) systolic pulmonary artery pressure <50 mmHg. Patients not matching these criteria were classified as VSTR. Patients with primary TR and cardiac implantable electronic device were excluded. Key endpoints included procedural success and survival at follow-up. A total of 298 patients were enrolled in the study: 65 (22%) with ASTR and 233 (78%) with VSTR. Procedural success was similar in the two groups (80% vs. 83% for ASTR vs. VSTR, p = 0.56) and TEER was effective in reducing TR in both groups (from 97% of patients with baseline TR >= 3+ to 23% in ASTR and to 15% in VSTR, all p = 0.001). At 12-month follow-up, survival was significantly higher in the ASTR versus VSTR cohort (91% vs. 72%, log-rank p = 0.02), with VSTR being an independent predictor of mortality at multivariable analysis (hazard ratio 4.75). Conclusions In a real-world, multicentre registry, T-TEER was effective in reducing TR grade in both ASTR and VSTR. At 12-month follow-up, ASTR showed better survival than VSTR.

Published
2023

22. 2-Year Outcomes after Transcatheter Mitral Valve Replacement: Results from the CHOICE-MI Registry

Author

Ludwig, S., additional, Ben, A. W., additional, Coisne, A., additional, Ruge, H., additional, Bleiziffer, S., additional, Weimann, J., additional, Duncan, A., additional, Nickenig, G., additional, Hausleiter, J., additional, Adam, M., additional, Dumonteil, N., additional, Sondergaard, L., additional, Garatti, A., additional, Schmidt, T., additional, Gry, D., additional, Maurizio, T., additional, Walther, T., additional, Kempfert, J., additional, Obadia, J. F., additional, Reardon, M., additional, Andreas, M., additional, Denti, P., additional, Praz, F., additional, Von, B. R.S., additional, Blankenberg, S., additional, Reichenspurner, H., additional, Modine, T., additional, and Conradi, L., additional

Published
2023
Full Text
View/download PDF

27. Staging heart failure patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair

Author

Stolz, L, primary, Karam, N, additional, Von Bardeleben, R S, additional, Pfister, R, additional, Petronio, A, additional, Butter, C, additional, Melica, B, additional, Praz, F, additional, Massberg, S, additional, Kalbacher, D, additional, Lurz, P, additional, Adamo, M, additional, Metra, M, additional, Bax, J J, additional, and Hausleiter, J, additional

Published
2022
Full Text
View/download PDF

28. Propofol versus midazolam sedation in patients with cardiogenic shock – an observational propensity-matched study

Author

Scherer, C, primary, Kleeberger, J, additional, Kellnar, A, additional, Binzenhoefer, L, additional, Luesebrink, E, additional, Stocker, T J, additional, Thienel, M, additional, Deseive, S, additional, Braun, D, additional, Petzold, T, additional, Brunner, S, additional, Hagl, C, additional, Hausleiter, J, additional, Massberg, S, additional, and Orban, M, additional

Published
2022
Full Text
View/download PDF

29. Characteristics and outcomes of normal-flow low-gradient aortic stenosis patients compared to high-gradient aortic stenosis patients undergoing TAVI

Author

Steffen, J, primary, Andreae, D, additional, Haum, M, additional, Fischer, J, additional, Doldi, P, additional, Peterss, S, additional, Hausleiter, J, additional, Rizas, K, additional, Braun, D, additional, Orban, M, additional, Nabauer, M, additional, Massberg, S, additional, and Deseive, S, additional

Published
2022
Full Text
View/download PDF

30. Transcatheter treatment for tricuspid valve disease

Author

Praz, F, Muraru, D, Kreidel, F, Lurz, P, Hahn, R, Delgado, V, Senni, M, Von Bardeleben, R, Nickenig, G, Hausleiter, J, Mangieri, A, Zamorano, J, Prendergast, B, Maisano, F, Praz F., Muraru D., Kreidel F., Lurz P., Hahn R. T., Delgado V., Senni M., Von Bardeleben R. S., Nickenig G., Hausleiter J., Mangieri A., Zamorano J. L., Prendergast B., Maisano F., Praz, F, Muraru, D, Kreidel, F, Lurz, P, Hahn, R, Delgado, V, Senni, M, Von Bardeleben, R, Nickenig, G, Hausleiter, J, Mangieri, A, Zamorano, J, Prendergast, B, Maisano, F, Praz F., Muraru D., Kreidel F., Lurz P., Hahn R. T., Delgado V., Senni M., Von Bardeleben R. S., Nickenig G., Hausleiter J., Mangieri A., Zamorano J. L., Prendergast B., and Maisano F.

Abstract

Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve disease. Secondary TR is more common and arises as a result of annular dilation caused by right ventricular enlargement and dysfunction as a consequence of pulmonary hypertension, often caused by left-sided heart disease or atrial fibrillation. Irrespective of its aetiology, TR leads to volume overload and increased wall stress, both of which negatively contribute to detrimental remodelling and worsening TR. This vicious circle translates into impaired survival and increased heart failure symptoms in patients with and without reduced left ventricular ejection fraction. Interventions to correct TR are underutilised in daily clinical practice owing to increased surgical risk and late patient presentation. The recently introduced transcatheter tricuspid valve interventions aim to address this unmet need. Dedicated expertise and an interdisciplinary Heart Team evaluation are essential to integrate these new techniques successfully and select patients. The present article proposes a standardised approach to evaluate patients with TR who may be candidates for transcatheter interventions. In addition, a state-of-the-art review of the available transcatheter therapies, the main criteria for patient and device selection, and information concerning the remaining uncertainties are provided.

Published
2021

32. Addendum to the position paper of the German Cardiac Society Interventional treatment of AV valvular diseases-Criteria for certification of mitral valve centers

Author

Baldus, S., Bardeleben, R. S., V, Eggebrecht, H., Elsasser, A., Hausleiter, J., Ince, H., Kelm, M., Kuck, K. H., Lubos, E., Nef, H., Raake, P., Rillig, A., Rudolph, V, Schulze, P. C., Schlitt, A., Stellbrink, C., Moellmann, H., Baldus, S., Bardeleben, R. S., V, Eggebrecht, H., Elsasser, A., Hausleiter, J., Ince, H., Kelm, M., Kuck, K. H., Lubos, E., Nef, H., Raake, P., Rillig, A., Rudolph, V, Schulze, P. C., Schlitt, A., Stellbrink, C., and Moellmann, H.

Published
2022

34. Characteristics and Outcomes of Patients Undergoing Screening for Transcatheter Mitral Valve Implantation: Results from the CHOICE-MI Registry

Author

Ludwig, S., additional, Ben, A. W., additional, Duncan, A., additional, Weimann, J., additional, Nickenig, G., additional, Hausleiter, J., additional, Baldus, S., additional, Ruge, H., additional, Von Bardeleben, R. S., additional, Walther, T., additional, Bleiziffer, S., additional, Kempfert, J., additional, Granada, J., additional, Tang, G., additional, Blankenberg, S., additional, Reichenspurner, H., additional, Modine, T., additional, and Conradi, L., additional

Published
2022
Full Text
View/download PDF

35. 1-Year Outcomes after Transcatheter Mitral Valve Implantation: Results from the Global CHOICE-MI Registry

Author

Ludwig, S., additional, Ben, A. W., additional, Duncan, A., additional, Weimann, J., additional, Nickenig, G., additional, Hausleiter, J., additional, Baldus, S., additional, Ruge, H., additional, Von Bardeleben, R. S., additional, Walther, T., additional, Bleiziffer, S., additional, Kempfert, J., additional, Granada, J., additional, Tang, G., additional, Blankenberg, S., additional, Reichenspurner, H., additional, Modine, T., additional, and Conradi, L., additional

Published
2022
Full Text
View/download PDF

37. Contributors

Author

Anagnostopoulos, C.D., primary, Badano, L.P., additional, Baksi, A.J., additional, Bekkers, S.C.A.M., additional, Bischoff, B., additional, Bissell, M.M., additional, Braun, D., additional, Budde, R.P.J., additional, Buechel, R.R., additional, Camilleri, S., additional, Cappeliez, O., additional, Chow, B.J.W., additional, Coenen, A., additional, Cosyns, B., additional, Crean, A.M., additional, Dijkshoorn, M., additional, Donal, E., additional, Edvardsen, T., additional, Fernández-Golfín, C., additional, Ferreira, V.M., additional, Flotats, A., additional, Gaemperli, O., additional, Galderisi, M., additional, Galli, E., additional, Gaubert, J.-Y., additional, Gerber, B.L., additional, Gimelli, A., additional, Goetschalckx, K., additional, Greenwood, J.P., additional, Gurunathan, S., additional, Habets, J., additional, Habib, G., additional, Hasselberg, N.E., additional, Hausleiter, J., additional, Karamitsos, T.D., additional, Kaufmann, P.A., additional, Kietselaer, B.L., additional, Knaapen, P., additional, Lancellotti, P., additional, Lederlin, M., additional, Leeson, P., additional, Leiner, T., additional, Lombardi, M., additional, Lubberink, M., additional, Ludman, A.J., additional, Magalhães, T.A., additional, Mahjoub, H., additional, Mahnken, A., additional, Manrique, A., additional, Marra, M.P., additional, Motwani, M., additional, Muraru, D., additional, Neubauer, S., additional, Nieman, K., additional, Paelinck, B., additional, Pasquet, A.A., additional, Pennell, D.J., additional, Petersen, S.E., additional, Pibarot, P., additional, Pison, L., additional, Plein, S., additional, Polsani, V., additional, Premaratne, M., additional, Pugliese, F., additional, Rademakers, F.E., additional, Robson, M.D., additional, Rochitte, C.E., additional, Salgado, R., additional, Schulz-Menger, J., additional, Senior, R., additional, Singh, P., additional, Tawakol, A., additional, Tyler, D.J., additional, Vannan, M., additional, Wassmuth, R., additional, Zamorano, J., additional, and Zhou, X., additional

Published
2015
Full Text
View/download PDF

39. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries

Author

Mehr M, Karam N, Taramasso M, Ouarrak T, Schneider S, Lurz P, von Bardeleben RS, Fam N, Pozzoli A, Lubos E, Boekstegers P, Schillinger W, Plicht B, Eggebrecht H, Baldus S, Senges J, Maisano F, Hausleiter J, TriValve, Investigators T, Mehr, M, Karam, N, Taramasso, M, Ouarrak, T, Schneider, S, Lurz, P, von Bardeleben, R, Fam, N, Pozzoli, A, Lubos, E, Boekstegers, P, Schillinger, W, Plicht, B, Eggebrecht, H, Baldus, S, Senges, J, Maisano, F, Hausleiter, J, Trivalve, and Investigators, T

Published
2020

40. Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure

Author

Orban M, Rommel KP, Ho EC, Unterhuber M, Pozzoli A, Connelly KA, Deseive S, Besler C, Ong G, Braun D, Edwards J, Miura M, Gulmez G, Stolz L, Gavazzoni M, Zuber M, Nabauer M, Maisano F, Thiele H, Massberg S, Taramasso M, Fam NP, Lurz P, Hausleiter J, Orban, M, Rommel, Kp, Ho, Ec, Unterhuber, M, Pozzoli, A, Connelly, Ka, Deseive, S, Besler, C, Ong, G, Braun, D, Edwards, J, Miura, M, Gulmez, G, Stolz, L, Gavazzoni, M, Zuber, M, Nabauer, M, Maisano, F, Thiele, H, Massberg, S, Taramasso, M, Fam, Np, Lurz, P, and Hausleiter, J

Published
2020

41. ADP-receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysis

Author

Kleeberger, J A, primary, Ouarrak, T, additional, Freund, A, additional, Fuernau, G, additional, Geissler, T, additional, Huber, K, additional, Noc, M, additional, Montalescot, G, additional, Clemmensen, P, additional, Zeymer, U, additional, Desch, S, additional, Schneider, S, additional, Hausleiter, J, additional, Thiele, H, additional, and Orban, M, additional

Published
2021
Full Text
View/download PDF

43. Impact of the cardio-hepatic syndrome on outcomes after transcatheter mitral valve edge-to-edge repair

Author

Stolz, L, primary, Orban, M, additional, Karam, N, additional, Lubos, E, additional, Wild, M, additional, Praz, F, additional, Braun, D, additional, Doldi, P, additional, Tence, N, additional, Hagl, C, additional, Mayerle, J, additional, Naebauer, M, additional, Kalbacher, D, additional, Massberg, S, additional, and Hausleiter, J, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results